Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
and $26 price target on Pfizer Inc. (NYSE:PFE), citing the pharma giant's key hurdles. Pfizer is facing the first of three years of rising patent-cliff strain on its profit margins, as its business development capacity has been slashed to $6 billion and dividend growth has stagnated for the very first time in 16 years. Pixabay/Public Domain According to Goldman Sachs, a price rebound will most likely be driven by 2026 clinical catalysts, with investors focusing especially on obesity updates given Pfizer's recent MTSR acquisition, which puts the company back in the weight loss therapy race. The coming VESPER-3 monthly data, which could be released in the initial half of 2026 instead of the first quarter, as originally said, is expected to be the most crucial mood driver for PFE shares this year. Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the US and internationally. The company offers medicines and vacc
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Trump administration to launch TrumpRx website for discounted drugs [Los Angeles Times (CA)]Los Angeles Times
- Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off [Yahoo! Finance Canada]Yahoo! Finance Canada
- ??????????????????? - ??????????????????2026-2035? [CNET News]CNET News
- ??????????????????????????: 2032????19?8813?????????? [CNET News]CNET News
- Jim Cramer Expresses Concern About Pfizer Despite Its “Terrific Yield” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 2/3/26 - Form 8-K
- 2/2/26 - Form 4
- 1/16/26 - Form 4
- PFE's page on the SEC website